Skip to Content

b 213 750 (Niacin Extended-Release 750 mg)

Pill with imprint b 213 750 is White, Capsule-shape and has been identified as Niacin Extended-Release 750 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Niacin is used in the treatment of high cholesterol; depression; niacin deficiency; hyperlipoproteinemia; pellagra (and more), and belongs to the drug classes miscellaneous antihyperlipidemic agents, vitamins. Risk cannot be ruled out during pregnancy. Niacin 750 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for b 213 750

Niacin Extended-Release

Imprint:
b 213 750
Strength:
750 mg
Color:
White
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Miscellaneous antihyperlipidemic agents
Vitamins
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC):
00093-7393

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide